000			02336 a2200685 4500
005			20250516084513.0
264		0	_c20130710
008			201307s 0 0 eng d
022			_a1876-4479
024	7		_a10.1016/j.crohns.2012.03.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aPapa, Alfredo
245	0	0	_aPrevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents. _h[electronic resource]
260			_bJournal of Crohn's & colitis _cMar 2013
300			_a113-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdalimumab
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAnalysis of Variance
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aColitis, Ulcerative _xdiagnosis
650	0	4	_aCrohn Disease _xdiagnosis
650	0	4	_aDNA, Viral _xblood
650	0	4	_aFemale
650	0	4	_aHepacivirus _ximmunology
650	0	4	_aHepatitis B Antibodies _xblood
650	0	4	_aHepatitis B Surface Antigens _xblood
650	0	4	_aHepatitis B Vaccines
650	0	4	_aHepatitis B virus _ximmunology
650	0	4	_aHepatitis B, Chronic _xepidemiology
650	0	4	_aHepatitis C Antibodies _xblood
650	0	4	_aHepatitis C, Chronic _xepidemiology
650	0	4	_aHumans
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrevalence
650	0	4	_aRNA, Viral _xblood
650	0	4	_aROC Curve
650	0	4	_aTime Factors
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aYoung Adult
700	1		_aFelice, Carla
700	1		_aMarzo, Manuela
700	1		_aAndrisani, Gianluca
700	1		_aArmuzzi, Alessandro
700	1		_aCovino, Marcello
700	1		_aMocci, Giammarco
700	1		_aPugliese, Daniela
700	1		_aDe Vitis, Italo
700	1		_aGasbarrini, Antonio
700	1		_aRapaccini, Gian Lodovico
700	1		_aGuidi, Luisa
773	0		_tJournal of Crohn's & colitis _gvol. 7 _gno. 2 _gp. 113-9
856	4	0	_uhttps://doi.org/10.1016/j.crohns.2012.03.001 _zAvailable from publisher's website
999			_c21667491 _d21667491